Narrow search
Showing 1 - 10 of 17,433
Cover Image
Endogenous cost-effectiveness analysis and health care technology adoption
Jena, Anupam B.; Philipson, Tomas J. - In: Journal of health economics 32 (2013) 1, pp. 172-180
Persistent link: https://www.econbiz.de/10009703545
Cover Image
Assessing market power in regimes of rapid technological change
Hartman, Raymond S. (contributor) - In: Industrial and corporate change 2 (1993) 3, pp. 317-350
Persistent link: https://www.econbiz.de/10001154227
Cover Image
Determinanten der Innovation und Diffusion des medizinisch-technischen Fortschritts
Bantle, Roland - 1996
Persistent link: https://www.econbiz.de/10013420480
Cover Image
Geographies of knowledge and learning : the example of medical technology
Hermelin, Brita; Dahlström, Margareta; Smas, Lukas - In: Growth and change : a journal of urban and regional policy 45 (2014) 3, pp. 450-470
Persistent link: https://www.econbiz.de/10011334276
Cover Image
Regional patterns in medical technology utilization
Hall, Anne E. - 2015
Persistent link: https://www.econbiz.de/10011406291
Cover Image
"Health Economics" and the evolution of economic evaluation of health technologies
Hutton, John - In: Health economics 21 (2012) 1, pp. 13-18
Persistent link: https://www.econbiz.de/10009424732
Cover Image
Wristop: market selection for medical technologies
Malinen, Pasi; Cooney, Thomas M. - In: Piccola impresa (2012) 1, pp. 125-135
Persistent link: https://www.econbiz.de/10009619113
Cover Image
Medizinisch-technischer Fortschritt und altersspezifische Gesundheitsausgaben
Ried, Walter - In: Jahrbücher für Nationalökonomie und Statistik 227 (2007) 5/6, pp. 636-659
Persistent link: https://www.econbiz.de/10003712112
Cover Image
Bestimmungsgründe für den medizinischen Fortschritt
Arnold, Robert - In: Jahrbücher für Nationalökonomie und Statistik 227 (2007) 5/6, pp. 681-698
Persistent link: https://www.econbiz.de/10003712127
Cover Image
Evaluation of Medical Technologies with Uncertain Benefits
Lakdawalla, Darius N. - 2019
Cost-effectiveness analysis (CEA) remains the de-facto method of choice to evaluate and compare medical interventions. Standard approaches to CEA use the average (mean) outcomes from clinical effectiveness studies such as randomized controlled trials. This paper generalizes standard methods to...
Persistent link: https://www.econbiz.de/10012480006